Structure Therapeutics In... (GPCR)

15.81

-1.50 (-8.67%)

At close: Apr 01, 2025, 3:59 PM

16.03

1.38%

After-hours: Apr 01, 2025, 07:33 PM EDT

Structure Therapeutics Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-122.53M	-89.62M	-51.32M	-38.05K	-15.88K
Depreciation & Amortization	992K	295K	277K	72.00	20.03K
Stock-Based Compensation	18.79M	8.19M	2.51M	1.49M	570K
Other Working Capital	-343K	7.83M	815K	2.17K	-74
Other Non-Cash Items	-16.86M	-5.32M	-558K	241.00	77.00
Deferred Income Tax	n/a	n/a	n/a	27.00	-20.03K
Change in Working Capital	2.96M	6.97M	2.97M	4.06K	946.00
Operating Cash Flow	-116.64M	-79.49M	-46.12M	-32.16K	-14.28K
Capital Expenditures	-1.29M	-2.17M	-155K	-1.21K	-19
Acquisitions	n/a	n/a	61.95K	-19.07K	n/a
Purchase of Investments	-702.52M	-416.99M	-123.45M	-4.21K	-21.13K
Sales Maturities Of Investments	344.9M	151.05M	61.5M	23.28K	n/a
Other Investing Acitivies	n/a	-231.38K	-61.95K	19.07K	-21.13K
Investing Cash Flow	-358.91M	-268.34M	-62.11M	17.86K	-21.15K
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-6K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	690K	-20.77M	-2.48M	-103.25M	n/a
Financial Cash Flow	515.26M	451.53M	29.01M	103.25K	25.84K
Net Cash Flow	39.72M	103.7M	-79.21M	88.95K	-9.59K
Free Cash Flow	-117.93M	-81.66M	-46.27M	-33.37K	-14.3K